Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-09

Clinical Trial Update: 1% Clascoterone Cream for the Treatment Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 1% clascoterone cream for acne vulgaris is not yet recruiting. The sponsor is Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clascoterone cream 1% (clascoterone)

Snippet

Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Conditions: Acne Vulgaris | Phase 3 | Status: NOT_YET_RECRUITING